Mechanisms underlying the blood pressure‐lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes: A secondary analysis of a randomized crossover trial-Reference-Cited by-同舟云学术

Mechanisms underlying the blood pressure‐lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes: A secondary analysis of a randomized crossover trial

Published:2022-09-27 Issue:1 Volume:25 Page:198-207
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Scholtes Rosalie A.¹^ORCID,Mosterd Charlotte M.¹,Hesp Anne C.¹,Smits Mark M.¹²,Heerspink Hiddo J. L.³^ORCID,van Raalte Daniël H.¹

Affiliation:

1. Diabetes Center, Department of Internal Medicine Amsterdam University Medical Centers Amsterdam The Netherlands

2. Department of Biomedical Sciences, Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark

3. Department of Clinical Pharmacy and Pharmacology University Medical Center Groningen Groningen The Netherlands

Funder

Boehringer Ingelheim

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14864

Reference55 articles.

1. Cardiovascular Outcomes in Framingham Participants With Diabetes

2. SYMPATHETIC NERVOUS SYSTEM, DIABETES, AND HYPERTENSION

3. Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDM

4. Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reaffirmation of Mechanistic Proteomic Signatures Accompanying SGLT2 Inhibition in Patients With Heart Failure;Journal of the American College of Cardiology;2024-08

2. c. Part III: Treatment with Antidiabetes Drugs—Effects on Blood Pressure and Central Hemodynamics;Early Vascular Aging (EVA);2024

3. Critical Analysis of the Effects of SGLT2 Inhibitors on Renal Tubular Sodium, Water and Chloride Homeostasis and Their Role in Influencing Heart Failure Outcomes;Circulation;2023-07-25

4. Canagliflozin Ameliorates Oxidative Stress and Autistic-like Features in Valproic-Acid-Induced Autism in Rats: Comparison with Aripiprazole Action;Pharmaceuticals;2023-05-19